The new highs list remains depleted since a sharp downdraft in the major averages. A few stocks though, like biotech Incyte (INCY) bucked the trend Monday, only to give back gains by the close. The big-cap stock hit a new high and briefly cleared a 121.80 consolidation buy point before reversing. Volume was almost 60% above average.